Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122737565 | 12273756 | 5 | F | 20140505 | 20160928 | 20160415 | 20160930 | PER | US-PFIZER INC-2016213451 | PFIZER | 53.00 | YR | M | Y | 0.00000 | 20160930 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122737565 | 12273756 | 1 | PS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, 4X/DAY (FOUR TIMES A DAY) | U | 84349 | 100 | MG | CAPSULE, HARD | QID | |||||
| 122737565 | 12273756 | 2 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 400 MG, DAILY (PER DAY AT BED TIME) | U | 84349 | 400 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 3 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 500 MG, DAILY (PER DAY) | U | 84349 | 500 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 4 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, UNK | U | 84349 | 100 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 5 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 30 MG, UNK | U | 84349 | 30 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 6 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 400 MG, 1X/DAY (100 MG 4 CAPSULES AT BED TIME) | U | 84349 | 400 | MG | CAPSULE, HARD | QD | |||||
| 122737565 | 12273756 | 7 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 400 MG, DAILY | U | 84349 | 400 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 8 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 500 MG, 1X/DAY (100 MG 5 CAPSULES AT BED TIME) | U | 84349 | 500 | MG | CAPSULE, HARD | QD | |||||
| 122737565 | 12273756 | 9 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 500 MG, DAILY | U | 84349 | 500 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 10 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 300 MG, 1X/DAY (100 MG 3 CAPSULES AT BED TIME) | U | 84349 | 300 | MG | CAPSULE, HARD | QD | |||||
| 122737565 | 12273756 | 11 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, DAILY | U | 84349 | 100 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 12 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, DAILY | U | 84349 | 100 | MG | CAPSULE, HARD | ||||||
| 122737565 | 12273756 | 13 | SS | DILANTIN | PHENYTOIN | 1 | Oral | 100 MG, DAILY | U | 84349 | 100 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122737565 | 12273756 | 1 | Epilepsy |
| 122737565 | 12273756 | 2 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122737565 | 12273756 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122737565 | 12273756 | Cerebellar atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122737565 | 12273756 | 1 | 20041208 | 0 | ||
| 122737565 | 12273756 | 2 | 200501 | 0 | ||
| 122737565 | 12273756 | 3 | 200511 | 0 | ||
| 122737565 | 12273756 | 4 | 20090505 | 0 | ||
| 122737565 | 12273756 | 5 | 20090806 | 0 | ||
| 122737565 | 12273756 | 6 | 20101123 | 0 | ||
| 122737565 | 12273756 | 7 | 20100319 | 0 | ||
| 122737565 | 12273756 | 8 | 20121207 | 0 | ||
| 122737565 | 12273756 | 9 | 20130529 | 0 | ||
| 122737565 | 12273756 | 10 | 20140507 | 0 | ||
| 122737565 | 12273756 | 11 | 19970428 | 0 | ||
| 122737565 | 12273756 | 12 | 19991121 | 0 | ||
| 122737565 | 12273756 | 13 | 20010117 | 0 |